Fiera Capital Corp Neurocrine Biosciences Inc Transaction History

Fiera Capital Corp

$29.1 Billion
Q3 2025

A detailed history of Fiera Capital Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fiera Capital Corp holds 479,676 shares of NBIX stock, worth $69.5 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

479,676

Previous 490,594 2.23%

Holding current value

$69.5 Million

Previous $61.7 Million 9.2%

% of portfolio

0.23%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$123.98 - $146.67 $1.35 Million - $1.6 Million	-10,918 Reduced 2.23%	479,676 $67.3 Million
Q2 2025 Aug 08, 2025	SELL	$87.54 - $128.18 $339,742 - $497,466	-3,881 Reduced 0.78%	490,594 $61.7 Million
Q1 2025 May 07, 2025	SELL	$107.22 - $153.29 $496,857 - $710,345	-4,634 Reduced 0.93%	494,475 $54.7 Million
Q4 2024 Jan 29, 2025	SELL	$111.62 - $139.44 $1.97 Million - $2.47 Million	-17,692 Reduced 3.42%	499,109 $68.1 Million
Q3 2024 Nov 01, 2024	SELL	$114.58 - $153.15 $1.27 Million - $1.7 Million	-11,101 Reduced 2.1%	516,801 $59.5 Million

Q2 2024 Aug 01, 2024	BUY	$130.86 - $143.19 $2.14 Million - $2.34 Million	16,360 Added 3.2%	527,902 $72.7 Million
Q1 2024 Aug 22, 2024	SELL	$130.4 - $143.74 $2.13 Million - $2.35 Million	-16,360 Reduced 3.1%	511,542 $70.6 Million
Q1 2024 May 01, 2024	SELL	$130.4 - $143.74 $694,119 - $765,128	-5,323 Reduced 1.03%	511,542 $70.6 Million
Q4 2023 Aug 22, 2024	BUY	$106.07 - $132.76 $583,066 - $729,781	5,497 Added 1.07%	516,865 $68.1 Million
Q4 2023 Feb 08, 2024	BUY	$106.07 - $132.76 $583,066 - $729,781	5,497 Added 1.07%	516,865 $68.1 Million
Q3 2023 Aug 22, 2024	SELL	$94.02 - $117.1 $1.55 Million - $1.94 Million	-16,534 Reduced 3.13%	511,368 $57.5 Million
Q3 2023 Nov 09, 2023	BUY	$94.02 - $117.1 $14.4 Million - $18 Million	153,393 Added 42.85%	511,368 $57.5 Million
Q2 2023 Aug 09, 2023	SELL	$89.53 - $104.87 $1.02 Million - $1.19 Million	-11,392 Reduced 3.08%	357,975 $33.8 Million
Q1 2023 Apr 26, 2023	SELL	$94.11 - $123.02 $296,634 - $387,759	-3,152 Reduced 0.85%	369,367 $37.4 Million
Q4 2022 Feb 08, 2023	SELL	$106.72 - $127.06 $274,056 - $326,290	-2,568 Reduced 0.68%	372,519 $44.5 Million
Q3 2022 Nov 03, 2022	SELL	$92.03 - $107.81 $342,259 - $400,945	-3,719 Reduced 0.98%	375,087 $37.5 Million
Q2 2022 Aug 10, 2022	SELL	$75.79 - $100.07 $369,855 - $488,341	-4,880 Reduced 1.27%	378,806 $36.9 Million
Q1 2022 May 09, 2022	BUY	$72.45 - $94.81 $1.44 Million - $1.88 Million	19,814 Added 5.45%	383,686 $36 Million
Q4 2021 Feb 08, 2022	SELL	$79.65 - $106.22 $3.07 Million - $4.1 Million	-38,600 Reduced 9.59%	363,872 $31 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $550,690 - $632,801	-6,390 Reduced 1.56%	402,472 $38.6 Million
Q2 2021 Aug 11, 2021	SELL	$89.43 - $102.27 $835,991 - $956,019	-9,348 Reduced 2.24%	408,862 $49.9 Million
Q1 2021 May 11, 2021	BUY	$87.57 - $119.4 $519,640 - $708,519	5,934 Added 1.44%	418,210 $40.7 Million
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $11 Million - $13.7 Million	126,651 Added 44.34%	412,276 $39.5 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $27.5 Million - $38.6 Million	285,625 New	285,625 $27.5 Million

Others Institutions Holding NBIX

# of Institutions

744

Shares Held

103M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Neurocrine Biosciences Inc Transaction History